Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
株式のランク
#2196
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
株価
$3.40
時価総額
$9.07B
変化（1日）
-1.61%
変化（1年）
-16.08%
国
CN
取引 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
カテゴリー
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.（600196）の発行済株式数
October 2026 時点の発行済株式数 0
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 0 です。October 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.（600196）の発行済株式数の履歴（2001 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2025 | 2.65B | -0.64% |
| 2024 | 2.66B | -0.67% |
| 2023 | 2.68B | 2.83% |
| 2022 | 2.61B | 1.74% |
| 2021 | 2.56B | 0.00% |
| 2020 | 2.56B | 0.00% |
| 2019 | 2.56B | 1.60% |
| 2018 | 2.52B | 2.55% |
| 2017 | 2.46B | 6.08% |
| 2016 | 2.32B | 0.86% |
| 2015 | 2.30B | 0.11% |
| 2014 | 2.30B | 3.03% |
| 2013 | 2.23B | 14.02% |
| 2012 | 1.95B | 2.31% |
| 2011 | 1.91B | 1.77% |
| 2010 | 1.88B | 1.46% |
| 2009 | 1.85B | 0.00% |
| 2008 | 1.85B | 0.54% |
| 2007 | 1.84B | 8.49% |
| 2006 | 1.70B | -3.52% |
| 2005 | 1.76B | 0.00% |
| 2004 | 1.76B | 0.00% |
| 2003 | 1.76B | 0.00% |
| 2002 | 1.76B | 0.00% |
| 2001 | 1.76B | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
